This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Towards the clinical implementation of pharmacogenetics in bipolar disorder
BMC Medicine Open Access 30 May 2014
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Müller DJ, Schulze TG, Knapp M, Held T, Krauss H, Weber T et al. Acta Psychiatrica Scand 2001; 104: 375–379.
Zai CC, Hwang RW, DeLuca V, Muller DJ, King N, Zai GC et al. Int J Neuropsychopharmacol 2006; Sep 7: 1–13.
Chen CH, Wei FC, Koong FJ, Hsiao KJ . Biol Psychiatry 1997; 41: 827–829.
Inada T, Arinami T, Yagi G . Int J Neuropsychopharmacol 1999; 2: 181–186.
Hori H, Ohmori O, Shinkai T, Kojima H, Nakamura J . Am J Med Genet 2001; 105B: 774–778.
Chong SA, Tan EC, Tan CH, Mythily CH, Chan YH . Am J Med Genet 2003; 116B: 51–54.
Segman RH, Goltser T, Heresco-Levy U, Finkel B, Shalem R, Schlafman M et al. Pharmacogenomics J 2003; 3: 277–283.
Liou Y-J, Lai I-C, Liao D-L, Chen J-Y, Bai Y-M, Chen T-T et al. Schizophr Res 2006; 86: 323–325.
Bakker PR, van Harten PN, van Os J . Schizophr Res 2006; 83: 185–192.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zai, C., De Luca, V., Hwang, R. et al. Meta-analysis of two dopamine D2 receptor gene polymorphisms with tardive dyskinesia in schizophrenia patients. Mol Psychiatry 12, 794–795 (2007). https://doi.org/10.1038/sj.mp.4002023
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.mp.4002023
This article is cited by
-
The genetics of drug-related movement disorders, an umbrella review of meta-analyses
Molecular Psychiatry (2020)
-
Towards the clinical implementation of pharmacogenetics in bipolar disorder
BMC Medicine (2014)
-
Pharmacogenetic Applications and Pharmacogenomic Approaches in Schizophrenia
Current Genetic Medicine Reports (2013)
-
Do Tardive Dyskinesia and l-Dopa Induced Dyskinesia Share Common Genetic Risk Factors? An Exploratory Study
Journal of Molecular Neuroscience (2013)
-
Risk for antipsychotic-induced extrapyramidal symptoms: influence of family history and genetic susceptibility
Psychopharmacology (2011)